menu
    • menu

    Company profile for Selecta Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. Selecta plans to combine its tolerogenic Synthetic Vaccine Particles (SVP™) to a range of biologics for rare and serious diseases that require new treatment options. The company’s current proprietary pipeline includes SVP-enabled enzyme, oncol...
    Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. Selecta plans to combine its tolerogenic Synthetic Vaccine Particles (SVP™) to a range of biologics for rare and serious diseases that require new treatment options. The company’s current proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. SEL-212, the company’s lead candidate in Phase 2, is being developed to treat severe gout patients and resolve their debilitating symptoms, including flares and gouty arthritis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Selecta BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    480 Arsenal Way Watertown, MA 02472
    Telephone
    Telephone
    617-923-1400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://selectabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Selecta fuses with Cartesian in reverse merger
    Selecta fuses with Cartesian in reverse merger

    13 Nov 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/selecta-fuses-cartesian-reverse-merger-bolstering-finances-autoimmune-cell-therapy-goals

    Max Bayer FIERCE BIOTECH
    13 Nov 2023
    Share Share
    Selecta Biosciences Announces Merger with Cartesian Therapeutics
    Selecta Biosciences Announces Merger with Cartesian Therapeutics

    13 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/13/2779033/0/en/Selecta-Biosciences-Announces-Merger-with-Cartesian-Therapeutics.html

    GLOBENEWSWIRE
    13 Nov 2023
    Share Share
    Selecta Announces Transition of Clinical Operations of ImmTOR for SEL-212
    Selecta Announces Transition of Clinical Operations of ImmTOR for SEL-212

    31 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/31/2770616/0/en/Selecta-Announces-Transition-of-Manufacturing-and-Clinical-Operations-of-ImmTOR-for-SEL-212-to-Commercialization-Partner-Sobi.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    Selecta Biosciences Reports Second Quarter 2023 Financial Results
    Selecta Biosciences Reports Second Quarter 2023 Financial Results

    17 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/17/2727105/0/en/Selecta-Biosciences-Reports-Second-Quarter-2023-Financial-Results-and-Updates-on-Strategic-Initiative-Designed-to-Maximize-Stockholder-Value-Associated-with-SEL-212-Economics.html

    GLOBENEWSWIRE
    17 Aug 2023
    Share Share
    Selecta narrows focus to gout drug, freezing rest of pipeline
    Selecta narrows focus to gout drug, freezing rest of pipeline

    17 Aug 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/selecta-narrows-focus-gout-drug-freezing-investment-rest-pipeline

    James Waldron FIERCE BIOTECH
    17 Aug 2023
    Share Share
    Selecta Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212
    Selecta Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212

    31 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/31/2679221/0/en/Selecta-Biosciences-Announces-Presentation-of-Data-from-Phase-3-DISSOLVE-Program-of-SEL-212-in-Chronic-Refractory-Gout-During-Late-Breaking-Session-at-the-EULAR-2023-European-Congr.html

    GLOBENEWSWIRE
    31 May 2023
    Share Share

    ABOUT THIS PAGE

    Contact Selecta Biosciences and get a quotation

    Selecta Biosciences is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Sirolimus bulk with DMF offered by Selecta Biosciences

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search